These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34398476)

  • 61. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation.
    Rajagopal K; Daneshmand MA; Patel CB; Ganapathi AM; Schechter MA; Rogers JG; Milano CA
    J Thorac Cardiovasc Surg; 2013 May; 145(5):1373-9. PubMed ID: 23312101
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio.
    John R; Kanwar MK; Cleveland JC; Uriel N; Naka Y; Salerno C; Horstmanshof D; Hall SA; Cowger JA; Heatley G; Somo SI; Mehra MR
    J Thorac Cardiovasc Surg; 2023 Dec; 166(6):1684-1694.e18. PubMed ID: 35643769
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of longer term left ventricular assist device support on valvular regurgitation.
    Holman WL; Bourge RC; Fan P; Kirklin JK; Pacifico AD; Nanda NC
    ASAIO J; 1994; 40(3):M454-9. PubMed ID: 8555557
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preexisting mitral valve prosthesis in patients undergoing left ventricular assist device implantation.
    Schweiger M; Stepanenko A; Vierecke J; Drews T; Potapov E; Hetzer R; Krabatsch T
    Artif Organs; 2012 Jan; 36(1):49-53. PubMed ID: 21951108
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MitraClip procedure prior to left ventricular assist device implantation.
    Dogan G; Hanke JS; Ricklefs M; Chatterjee A; Feldmann C; Mashaqi B; Deniz E; Haverich A; Schmitto JD
    J Thorac Dis; 2018 Jun; 10(Suppl 15):S1763-S1768. PubMed ID: 30034850
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predictors of residual mitral regurgitation after left ventricular assist device implantation.
    Kimura Y; Okumura T; Kazama S; Shibata N; Oishi H; Arao Y; Kuwayama T; Kato H; Yamaguchi S; Hiraiwa H; Kondo T; Morimoto R; Mutsuga M; Fujimoto K; Usui A; Murohara T
    Int J Artif Organs; 2021 Feb; 44(2):101-109. PubMed ID: 32677853
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Integrated reverse left and right ventricular remodelling after MitraClip implantation in functional mitral regurgitation: an echocardiographic study.
    Giannini C; Petronio AS; De Carlo M; Guarracino F; Conte L; Fiorelli F; Pieroni A; Di Bello V
    Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):95-103. PubMed ID: 23980060
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial.
    Machaalany J; Bilodeau L; Hoffmann R; Sack S; Sievert H; Kautzner J; Hehrlein C; Serruys P; Sénéchal M; Douglas P; Bertrand OF
    Am Heart J; 2013 May; 165(5):761-9. PubMed ID: 23622913
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inflow Cannula Position Influences Improvement in Mitral Regurgitation After Ventricular Assist Device Implantation.
    Pasrija C; Sawan MA; Sorensen E; Gammie JS; Madathil R; Tran D; Wang L; Ton VK; Feller E; Griffith BP; Kon ZN; Kaczorowski DJ
    ASAIO J; 2021 Apr; 67(4):423-429. PubMed ID: 33769997
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Valvular Regurgitation in a Biventricular Mock Circulatory Loop.
    Shehab S; Allida SM; Newton PJ; Robson D; Macdonald PS; Davidson PM; Jansz PC; Hayward CS
    ASAIO J; 2019 Aug; 65(6):551-557. PubMed ID: 30074964
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Right heart failure and benefits of adjuvant tricuspid valve repair in patients undergoing left ventricular assist device implantation.
    Fujita T; Kobayashi J; Hata H; Seguchi O; Murata Y; Yanase M; Nakatani T
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):802-7. PubMed ID: 24574450
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.
    Topilsky Y; Hasin T; Oh JK; Borgeson DD; Boilson BA; Schirger JA; Clavell AL; Frantz RP; Tsutsui R; Liu M; Maltais S; Kushwaha SS; Pereira NL; Park SJ
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):648-61. PubMed ID: 21940507
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transcatheter Mitral Valve Repair for Severe,Symptomatic Mitral Regurgitation in Patients with Left Ventricular Assist Devices.
    Raghunathan D; Arora A; Aman W; Nathan S; Jumean M; Gregoric ID; Kar B
    Methodist Debakey Cardiovasc J; 2021 Apr; 17(1):e1-e4. PubMed ID: 34104329
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of Preoperative Tricuspid and/or Mitral Regurgitation on Development of Late Right-Sided Heart Failure After Insertion of the HeartWare Left Ventricular Assist Device.
    Gonzalez-Fernandez O; Bouzas-Cruz N; Ferrera C; Woods A; Robinson-Smith N; Tovey S; Parry G; MacGowan GA; Schueler S
    Am J Cardiol; 2020 Jan; 125(2):236-243. PubMed ID: 31767121
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Extracorporeal membrane oxygenation as perioperative right ventricular support in patients with biventricular failure undergoing left ventricular assist device implantation.
    Scherer M; Sirat AS; Moritz A; Martens S
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):939-44; discussion 944. PubMed ID: 21071240
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The development of aortic insufficiency in left ventricular assist device-supported patients.
    Cowger J; Pagani FD; Haft JW; Romano MA; Aaronson KD; Kolias TJ
    Circ Heart Fail; 2010 Nov; 3(6):668-74. PubMed ID: 20739615
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Limited Utility of Tricuspid Valve Repair at the Time of Left Ventricular Assist Device Implantation.
    Song HK; Gelow JM; Mudd J; Chien C; Tibayan FA; Hollifield K; Naftel D; Kirklin J
    Ann Thorac Surg; 2016 Jun; 101(6):2168-74. PubMed ID: 27139368
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of Concomitant Tricuspid Valve Surgery With Left Ventricular Assist Device Implantation.
    Fujino T; Imamura T; Nitta D; Kim G; Smith B; Kalantari S; Nguyen A; Chung B; Narang N; Holzhauser L; Juricek C; Rodgers D; Song T; Ota T; Jeevanandam V; Burkhoff D; Sayer G; Uriel N
    Ann Thorac Surg; 2020 Sep; 110(3):918-924. PubMed ID: 32035052
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fate of functional mitral regurgitation and predictors of persistent mitral regurgitation after isolated aortic valve replacement.
    Joo HC; Chang BC; Cho SH; Youn YN; Yoo KJ; Lee S
    Ann Thorac Surg; 2011 Jul; 92(1):82-7. PubMed ID: 21601829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.